文献速递MDS 与骨髓增殖性肿瘤血栓与止血

费城染色体阴性骨髓增殖性肿瘤中的动脉血栓预测第二癌症:一项病例对照研究

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
PubMed 文献 · Blood · 2020-01-01

国际嵌套病例对照研究纳入647例MPN后发生第二癌症的病例和1234例匹配对照,发现MPN诊断后、第二癌症前的动脉血栓事件在病例组更高(6.2% vs 3.7%,P=.015),校正混杂因素后动脉血栓仍独立与癌风险相关(OR 1.97,95%CI 1.14-3.41),提示MPN后动脉事件患者需密切监测以早期发现癌。

要点

  • MPN后发生动脉血栓者第二癌症风险约增2倍(OR 1.97)。
  • 病例与对照的MPN类型、驱动突变和心血管危险因素可比。
  • MPN诊断后动脉事件患者应加强临床监测以早期发现癌。

核心结论

  • 费城染色体阴性MPN患者诊断后发生动脉血栓独立预测第二癌症风险。

研究设计与样本

  • 国际嵌套病例对照研究,纳入647例MPN后诊断第二癌症的病例,按中心、性别、MPN诊断年龄、诊断日期和MPN病程匹配最多3例无癌症史对照(n=1234)。

主要发现

  • MPN后、第二癌症前的血栓事件病例组高于对照组(11.6% vs 8.1%;P=.013)。
  • 动脉血栓事件病例组高于对照组(6.2% vs 3.7%;P=.015)。
  • MPN前血栓频率病例与对照相似(P=.462)。
  • 校正混杂因素后,动脉血栓与癌风险独立相关(OR 1.97;95%CI 1.14-3.41)。

临床怎么用

  • MPN诊断后发生动脉血栓的患者应进行仔细临床监测以早期发现癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control study, we recruited 647 patients with carcinoma, nonmelanoma skin cancer, hematological second cancer, and melanoma diagnosed concurrently or after MPN diagnosis. Up to 3 control patients without a history of cancer and matched with each case for center, sex, age at MPN diagnosis, date of diagnosis, and MPN disease duration were included (n = 1234). Cases were comparable to controls for MPN type, driver mutations and cardiovascular risk factors. The frequency of thrombosis preceding MPN was similar for cases and controls (P = .462). Thrombotic events after MPN and before second cancer were higher in cases than in controls (11.6% vs 8.1%; P = .013), because of a higher proportion of arterial thromboses (6.2% vs 3.7%; P = .015). After adjustment for confounders, the occurrence of arterial thrombosis remained independently associated with the risk of carcinoma (odds ratio, 1.97; 95% confidence interval, 1.14-3.41), suggesting that MPN patients experiencing arterial events after MPN diagnosis deserve careful clinical surveillance for early detection of carcinoma. This study was registered at www.clinicaltrials.gov as NCT03745378.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. De Stefano V, Ghirardi A, Masciulli A, et al. Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. Blood. 2020. PMID: 31869407. doi:10.1182/blood.2019002614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。